NDC 0173-0889

Krintafel

Tafenoquine Succinate

Krintafel is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Tafenoquine Succinate.

Product ID0173-0889_1ea81964-b3a3-42e1-9d3c-fbd5fed5d921
NDC0173-0889
Product TypeHuman Prescription Drug
Proprietary NameKrintafel
Generic NameTafenoquine Succinate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-01-22
Marketing CategoryNDA / NDA
Application NumberNDA210795
Labeler NameGlaxoSmithKline LLC
Substance NameTAFENOQUINE SUCCINATE
Active Ingredient Strength150 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0173-0889-13

30 TABLET, FILM COATED in 1 BOTTLE (0173-0889-13)
Marketing Start Date2019-01-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0173-0889-39 [00173088939]

Krintafel TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA210795
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-01-22

NDC 0173-0889-13 [00173088913]

Krintafel TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA210795
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-22

Drug Details

Active Ingredients

IngredientStrength
TAFENOQUINE SUCCINATE150 mg/1

OpenFDA Data

SPL SET ID:5cf989d5-36f5-4561-a30b-9fcb9deb6b6a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2109233
  • 2109239

  • Trademark Results [Krintafel]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    KRINTAFEL
    KRINTAFEL
    87219174 5950504 Live/Registered
    Glaxo Group Limited
    2016-10-28
    KRINTAFEL
    KRINTAFEL
    86076979 not registered Dead/Abandoned
    Glaxo Group Limited
    2013-09-27
    KRINTAFEL
    KRINTAFEL
    85017408 not registered Dead/Abandoned
    Glaxo Group Limited
    2010-04-19

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.